Correction: BMS Exec Pleads Guilty Over Plavix Deal

Law360, New York (April 6, 2009, 12:00 AM EDT) -- The former vice president of Bristol-Myers Squibb Co. pled guilty to charges of lying to government regulators about a furtive and anti-competitive patent deal for the blockbuster blood-thinning drug Plavix.

On Monday, the U.S. Department of Justice announced that Andrew Bodnar admitted to misleading the Federal Trade Commission about the patent deal BMS sought in order to reduce competition for Plavix, the world’s most widely prescribed blood-thinning drug.

Defying regulators in 2006, Bodnar, BMS' negotiator, tried to finesse a settlement with Apotex Corp. to keep a...
To view the full article, register now.